K. Mayer et al., ECTOPIC ACTIVATION OF LYMPHOID HIGH-MOBILITY GROUP-BOX TRANSCRIPTION FACTOR TCF-1 AND OVEREXPRESSION IN COLORECTAL-CANCER CELLS, International journal of cancer, 72(4), 1997, pp. 625-630
Physical interaction between the lymphoid high mobility group (HMG)-bo
x architectural transcription factors TCF/LEF and beta-catenin is asso
ciated with translocation of the heteromeric complex to the nucleus an
d regulation of target gene expression. Since formation of molecular c
omplexes among beta-catenin, E-cadherin, p300(apc) and TCF/LEF depends
on balanced expression of these constituents, we investigated the bio
synthesis of TCF-1 in colorectal cancer. Here we report detailed analy
ses of activation and overexpression of lymphoid transcription factor
TCF-1 in human colorectal cancer-derived cell lines. Northern blot ana
lyses revealed considerable steady-state expression levers of TCF-1 mR
NA of normal size. Genomic rearrangement of the 5' flanking region of
the TCF-1 gene was excluded as a cause of ectopic expression. By contr
ast, CAT-reporter constructs depending on a 515-bp T-cell-regulated TC
F-1 genomic upstream region were significantly activated in epithelial
tumor cells. RT-PCR analyses revealed a heterogeneic population of mR
NA isoforms due to alternative splicing in the TCF-1 gene. On Western
blots of colorectal cancer cells, the TCF-1-specific monoclonal antibo
dy 7H3 detected a similar heterogeneous spectrum of TCF-1 specific pol
ypeptide chains. Interestingly, overexpression of TCF-1-specific splic
e forms correlated with the metastatic behavior of the analyzed cells
and with overproduction of lymphoid tyrosine protein kinase p56(lck).
We conclude that ectopic expression of the HMG-box factor TCF-1 is ass
ociated with late events in tumor progression. (C) 1997 Wiley-Liss, In
c.